Company news
Q-linea Ab (OMXSTO:QLINEA) news
Every Q-linea Ab press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Q-linea announces FDA clearance of expanded ASTar blood testing menu
April 16, 2026
Q-linea announces shipment of two ASTar® instruments to Saudi Arabia
April 2, 2026
Q-linea announces changes in US commercial leadership
January 5, 2026
Q-linea signs first distribution agreement in South Asia
December 30, 2025
Q-linea AB (publ) (OMX: QLINEA) today announces it will provide ASTar® to Italian users of the Accelerate Pheno rapid AST system
December 29, 2025
Q-linea announces first two US hospital systems’ clinical implementation of ASTar®
December 23, 2025
Q-linea announces new organisation and changes in executive leadership team
November 20, 2025
Q-linea announces FDA submission for expanded claims for ASTar® BC G- panel
November 18, 2025
Q-linea resolves to carry out a directed issue of shares to a guarantor in connection with the completed preferential rights issue
November 17, 2025
Q-linea announces outcome of rights issue
November 11, 2025
Q-linea publishes prospectus in connection with the rights issue
October 22, 2025
Q-linea announces cost efficiency program to accelerate sales and marketing activities
October 22, 2025
Stuart Gander appointed CEO and Anders Ljunggren appointed deputy CEO of Q-linea AB
October 19, 2025